Annual Book Value
$555.19 M
-$85.38 M-13.33%
31 December 2023
Summary:
Atea Pharmaceuticals annual book value is currently $555.19 million, with the most recent change of -$85.38 million (-13.33%) on 31 December 2023. During the last 3 years, it has fallen by -$154.88 million (-21.81%). AVIR annual book value is now -21.81% below its all-time high of $710.08 million, reached on 31 December 2021.AVIR Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Book Value
$458.52 M
-$17.95 M-3.77%
30 September 2024
Summary:
Atea Pharmaceuticals quarterly book value is currently $458.52 million, with the most recent change of -$17.95 million (-3.77%) on 30 September 2024. Over the past year, it has dropped by -$96.67 million (-17.41%). AVIR quarterly book value is now -35.43% below its all-time high of $710.08 million, reached on 31 December 2021.AVIR Quarterly Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AVIR Book Value Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -17.4% |
| 3 y3 years | -21.8% | -35.4% |
| 5 y5 years | +1220.0% | +1025.0% |
AVIR Book Value High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -21.8% | at low | -35.4% | at low |
| 5 y | 5 years | -21.8% | +1220.0% | -35.4% | +699.3% |
| alltime | all time | -21.8% | +1220.0% | -35.4% | +699.3% |
Atea Pharmaceuticals Book Value History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $458.52 M(-3.8%) |
| June 2024 | - | $476.47 M(-5.5%) |
| Mar 2024 | - | $504.37 M(-9.2%) |
| Dec 2023 | $555.19 M(-13.3%) | $555.19 M(-4.6%) |
| Sept 2023 | - | $581.73 M(-3.4%) |
| June 2023 | - | $602.35 M(-2.6%) |
| Mar 2023 | - | $618.18 M(-3.5%) |
| Dec 2022 | $640.57 M | $640.57 M(-3.4%) |
| Sept 2022 | - | $663.19 M(+0.4%) |
| June 2022 | - | $660.46 M(-2.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $679.88 M(-4.3%) |
| Dec 2021 | $710.08 M(+29.6%) | $710.08 M(+22.1%) |
| Sept 2021 | - | $581.45 M(-2.7%) |
| June 2021 | - | $597.86 M(+2.0%) |
| Mar 2021 | - | $586.26 M(+7.0%) |
| Dec 2020 | $547.80 M(-1205.1%) | $547.80 M(-816.0%) |
| Sept 2020 | - | -$76.51 M(-167.9%) |
| June 2020 | - | $112.62 M(-327.2%) |
| Dec 2019 | -$49.57 M(+37.1%) | -$49.57 M |
| Dec 2018 | -$36.16 M | - |
FAQ
- What is Atea Pharmaceuticals annual book value?
- What is the all time high annual book value for Atea Pharmaceuticals?
- What is Atea Pharmaceuticals quarterly book value?
- What is the all time high quarterly book value for Atea Pharmaceuticals?
- What is Atea Pharmaceuticals quarterly book value year-on-year change?
What is Atea Pharmaceuticals annual book value?
The current annual book value of AVIR is $555.19 M
What is the all time high annual book value for Atea Pharmaceuticals?
Atea Pharmaceuticals all-time high annual book value is $710.08 M
What is Atea Pharmaceuticals quarterly book value?
The current quarterly book value of AVIR is $458.52 M
What is the all time high quarterly book value for Atea Pharmaceuticals?
Atea Pharmaceuticals all-time high quarterly book value is $710.08 M
What is Atea Pharmaceuticals quarterly book value year-on-year change?
Over the past year, AVIR quarterly book value has changed by -$96.67 M (-17.41%)